Joshua J Ofman

Summary

Affiliation: Amgen Inc
Country: USA

Publications

  1. ncbi request reprint Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions
    Walter L Straus
    AHCPR Southern California Evidence Based Practice Center, Los Angeles, California, USA
    Am J Gastroenterol 97:1951-8. 2002
  2. ncbi request reprint Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs
    Joshua J Ofman
    Cedars Sinai Health System and Zynx Health Inc, Los Angeles, California 90212, USA
    Arthritis Rheum 49:508-18. 2003
  3. ncbi request reprint A systematic review of diabetes disease management programs
    Kevin Knight
    PHAR, LLC, Los Angeles, CA 90025, USA
    Am J Manag Care 11:242-50. 2005
  4. ncbi request reprint Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review
    Joshua J Ofman
    Cedars Sinai Department of Medicine, Los Angeles, California, USA
    Am J Med 117:182-92. 2004
  5. ncbi request reprint Impairment in work productivity and health-related quality of life in patients with IBS
    Bonnie B Dean
    Cerner Health Insights, Los Angeles, California, USA
    Am J Manag Care 11:S17-26. 2005
  6. ncbi request reprint Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups
    Brennan M R Spiegel
    Veteran s Affairs Greater Los Angeles Healthcare System, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90073, USA
    Arthritis Rheum 53:185-97. 2005
  7. ncbi request reprint Effectiveness of proton pump inhibitors in nonerosive reflux disease
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California 90212, USA
    Clin Gastroenterol Hepatol 2:656-64. 2004
  8. ncbi request reprint Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis
    Joshua J Ofman
    Department of Medicine, Zynx Health A Cerner Company, Beverly Hills, California 90212, USA
    Am J Med 116:835-42. 2004
  9. ncbi request reprint Dyspepsia management in primary care: a decision analysis of competing strategies
    Brennan M R Spiegel
    Department of Medicine and Health Services Research, Cedars Sinai Medical Center, Los Angeles, California, USA
    Gastroenterology 122:1270-85. 2002
  10. ncbi request reprint How useful are unpublished data from the Food and Drug Administration in meta-analysis?
    Catherine H Maclean
    RAND, 1700 Main Street, M 23C, Santa Monica, CA 90407 2138, USA
    J Clin Epidemiol 56:44-51. 2003

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions
    Walter L Straus
    AHCPR Southern California Evidence Based Practice Center, Los Angeles, California, USA
    Am J Gastroenterol 97:1951-8. 2002
    ..Using alternative definitions, we assessed the relationship between NSAID use and dyspepsia...
  2. ncbi request reprint Meta-analysis of dyspepsia and nonsteroidal antiinflammatory drugs
    Joshua J Ofman
    Cedars Sinai Health System and Zynx Health Inc, Los Angeles, California 90212, USA
    Arthritis Rheum 49:508-18. 2003
    ..Using published and unpublished data sources, we sought to determine estimates of the risks of dyspepsia associated with NSAIDs...
  3. ncbi request reprint A systematic review of diabetes disease management programs
    Kevin Knight
    PHAR, LLC, Los Angeles, CA 90025, USA
    Am J Manag Care 11:242-50. 2005
    ..To systematically evaluate and synthesize published evidence regarding the effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care...
  4. ncbi request reprint Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review
    Joshua J Ofman
    Cedars Sinai Department of Medicine, Los Angeles, California, USA
    Am J Med 117:182-92. 2004
    ..To assess the clinical and economic effects of disease management in patients with chronic diseases...
  5. ncbi request reprint Impairment in work productivity and health-related quality of life in patients with IBS
    Bonnie B Dean
    Cerner Health Insights, Los Angeles, California, USA
    Am J Manag Care 11:S17-26. 2005
    ..Reduced work productivity and diminished QOL of these magnitudes may have substantial financial impact on employers...
  6. ncbi request reprint Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups
    Brennan M R Spiegel
    Veteran s Affairs Greater Los Angeles Healthcare System, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90073, USA
    Arthritis Rheum 53:185-97. 2005
    ..To appraise the cost-effectiveness of competing therapeutic strategies in patient cohorts eligible for aspirin prophylaxis with varying degrees of gastrointestinal (GI) and cardiovascular risk...
  7. ncbi request reprint Effectiveness of proton pump inhibitors in nonerosive reflux disease
    Bonnie B Dean
    Cerner Health Insights, Beverly Hills, California 90212, USA
    Clin Gastroenterol Hepatol 2:656-64. 2004
    ..We aimed to synthesize available data and determine the effectiveness of PPIs on symptom resolution in patients with NERD...
  8. ncbi request reprint Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis
    Joshua J Ofman
    Department of Medicine, Zynx Health A Cerner Company, Beverly Hills, California 90212, USA
    Am J Med 116:835-42. 2004
    ....
  9. ncbi request reprint Dyspepsia management in primary care: a decision analysis of competing strategies
    Brennan M R Spiegel
    Department of Medicine and Health Services Research, Cedars Sinai Medical Center, Los Angeles, California, USA
    Gastroenterology 122:1270-85. 2002
  10. ncbi request reprint How useful are unpublished data from the Food and Drug Administration in meta-analysis?
    Catherine H Maclean
    RAND, 1700 Main Street, M 23C, Santa Monica, CA 90407 2138, USA
    J Clin Epidemiol 56:44-51. 2003
    ..07) did not differ significantly or practically. Data from FDA reviews may be a viable data source for systematic reviews and meta-analyses but only after being subjected to the same methodologic scrutiny as published data...
  11. ncbi request reprint A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs
    Joshua J Ofman
    Southern California Evidence Based Practice Center, Department of Medicine, Cedars Sinai Health System, Beverly Hills 90212, USA
    J Rheumatol 29:804-12. 2002
    ..We synthesized the published and unpublished evidence to determine the least biased estimates of the risks of perforations, ulcers, and bleeds (PUB) associated with NSAID use from all study designs and all languages...